← Back to Search

Walking Shoes for Reducing Impact Forces

N/A
Recruiting
Led By David Burke, MD, MA
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women who identify as "healthy"
Women between the ages of 18-50
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one-time at enrollment, no follow-up
Awards & highlights

Study Summary

This trial will compare two types of shoes to see which is better for foot health.

Who is the study for?
This trial is for healthy women aged 18-50 in Atlanta who walk or run for exercise more than three times a week. It's not open to those with musculoskeletal injuries, significant musculoskeletal diseases, prisoners, non-English speakers/writers, or anyone unable to consent.Check my eligibility
What is being tested?
The study compares traditional everyday activity shoes from brands like ASICS and Nike against the OESH shoe designed to be flatter and less cushioned. The impact forces while walking will be evaluated.See study design
What are the potential side effects?
Since this trial involves evaluation of walking shoes rather than medication or medical procedures, side effects are minimal but may include discomfort in the feet or legs due to differences in shoe design.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I consider myself a healthy woman.
Select...
I am a woman aged between 18 and 50.
Select...
I am a woman living in the Atlanta, Georgia area.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one-time at enrollment, no follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and one-time at enrollment, no follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Differences in forces at the knee comparing three study arms
Differences in torques at the knee comparing three study arms
Secondary outcome measures
Differences in forces at the bilateral anterior and posterior superior spine comparing three study arms
Differences in forces at the heels comparing three study arms
Differences in forces at the lateral femoral condyles comparing three study arms
+9 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Nike Air Max 270Experimental Treatment1 Intervention
Nike Air Max 270
Group II: La Vida+Experimental Treatment1 Intervention
La Vida+
Group III: ASICS Women's Gel-Venture 6 Running-ShoeExperimental Treatment1 Intervention
ASICS Women's Gel-Venture 6 Running-Shoe

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,627 Previous Clinical Trials
2,560,740 Total Patients Enrolled
David Burke, MD, MAPrincipal InvestigatorEmory University

Media Library

OESH shoe Clinical Trial Eligibility Overview. Trial Name: NCT04197362 — N/A
Impact Forces Research Study Groups: Nike Air Max 270, ASICS Women's Gel-Venture 6 Running-Shoe, La Vida+
Impact Forces Clinical Trial 2023: OESH shoe Highlights & Side Effects. Trial Name: NCT04197362 — N/A
OESH shoe 2023 Treatment Timeline for Medical Study. Trial Name: NCT04197362 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What site did they apply to?
Emory Rehabilitation Hospital
What portion of applicants met pre-screening criteria?
Met criteria
~17 spots leftby Mar 2025